Moving new vaccines for tuberculosis through the regulatory process

Authors
Citation
Mj. Brennan, Moving new vaccines for tuberculosis through the regulatory process, CLIN INF D, 30, 2000, pp. S247-S249
Citations number
13
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
30
Year of publication
2000
Supplement
3
Pages
S247 - S249
Database
ISI
SICI code
1058-4838(200006)30:<S247:MNVFTT>2.0.ZU;2-N
Abstract
The development of novel vaccines for the prevention of tuberculosis is an area of intense interest for scientific researchers, public health agencies , and pharmaceutical manufacturers. Development of effective new vaccines d irected against tuberculosis for use in target populations will require clo se cooperation among several different international organizations, includi ng regulatory agencies responsible for evaluating the safety and effectiven ess of new biologics for human use.